{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:50:52Z","timestamp":1790254252994,"version":"4.1.0"},"reference-count":84,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA94056"],"award-info":[{"award-number":["P50 CA94056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA127001"],"award-info":[{"award-number":["P50 CA127001"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA16672"],"award-info":[{"award-number":["P30 CA16672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP160183"],"award-info":[{"award-number":["RP160183"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Tumors lack a well-regulated vascular supply of O2 and often fail to balance O2 supply and demand. Net O2 tension within many tumors may not only depend on O2 delivery but also depend strongly on O2 demand. Thus, tumor O2 consumption rates may influence tumor hypoxia up to true anoxia. Recent reports have shown that many human tumors in vivo depend primarily on oxidative phosphorylation (OxPhos), not glycolysis, for energy generation, providing a driver for consumptive hypoxia and an exploitable vulnerability. In this regard, IACS-010759 is a novel high affinity inhibitor of OxPhos targeting mitochondrial complex-I that has recently completed a Phase-I clinical trial in leukemia. However, in solid tumors, the effective translation of OxPhos inhibitors requires methods to monitor pharmacodynamics in vivo. Herein, 18F-fluoroazomycin arabinoside ([18F]FAZA), a 2-nitroimidazole-based hypoxia PET imaging agent, was combined with a rigorous test-retest imaging method for non-invasive quantification of the reversal of consumptive hypoxia in vivo as a mechanism-specific pharmacodynamic (PD) biomarker of target engagement for IACS-010759. Neither cell death nor loss of perfusion could account for the IACS-010759-induced decrease in [18F]FAZA retention. Notably, in an OxPhos-reliant melanoma tumor, a titration curve using [18F]FAZA PET retention in vivo yielded an IC50 for IACS-010759 (1.4 mg\/kg) equivalent to analysis ex vivo. Pilot [18F]FAZA PET scans of a patient with grade IV glioblastoma yielded highly reproducible, high-contrast images of hypoxia in vivo as validated by CA-IX and GLUT-1 IHC ex vivo. Thus, [18F]FAZA PET imaging provided direct evidence for the presence of consumptive hypoxia in vivo, the capacity for targeted reversal of consumptive hypoxia through the inhibition of OxPhos, and a highly-coupled mechanism-specific PD biomarker ready for translation.<\/jats:p>","DOI":"10.3390\/cells8121487","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T02:49:27Z","timestamp":1574390967000},"page":"1487","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-0975","authenticated-orcid":false,"given":"Seth T.","family":"Gammon","sequence":"first","affiliation":[{"name":"Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-4417","authenticated-orcid":false,"given":"Federica","family":"Pisaneschi","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi L.","family":"Bandi","sequence":"additional","affiliation":[{"name":"Translational Research to Advance Therapeutics and Innovation in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda G.","family":"Smith","sequence":"additional","affiliation":[{"name":"Translational Research to Advance Therapeutics and Innovation in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Sun","sequence":"additional","affiliation":[{"name":"Translational Research to Advance Therapeutics and Innovation in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-2948","authenticated-orcid":false,"given":"Florian","family":"Muller","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"De Groot","sequence":"additional","affiliation":[{"name":"Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Ackroyd","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Mawlawi","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.N.","family":"Vashisht Gopal","sequence":"additional","affiliation":[{"name":"Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Emilia","family":"Di Francesco","sequence":"additional","affiliation":[{"name":"Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Marszalek","sequence":"additional","affiliation":[{"name":"Translational Research to Advance Therapeutics and Innovation in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dewhirst","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Duke University School of Medicine, Durham, NC 27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Piwnica-Worms","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","article-title":"HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption","volume":"3","author":"Papandreou","year":"2006","journal-title":"Cell Metab."},{"key":"ref_2","unstructured":"West, J.B. (1999). Respiratory Physiology: The Essentials, Williams & Wilkins. [6th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0167-8140(00)00259-0","article-title":"Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix","volume":"57","author":"Cooper","year":"2000","journal-title":"Radiother. Oncol."},{"key":"ref_4","first-page":"869","article-title":"Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance","volume":"17","author":"Vaupel","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1158\/0008-5472.CAN-12-1085","article-title":"Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI","volume":"72","author":"Halle","year":"2012","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1528-1157.1959.tb04248.x","article-title":"The Contribution of Patho-Anatomical Research to the Problem of Epilepsy","volume":"1","author":"Scholz","year":"1959","journal-title":"Epilepsia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"140080","DOI":"10.1098\/rsos.140080","article-title":"Oxygen consumption dynamics in steady-state tumour models","volume":"1","author":"Grimes","year":"2014","journal-title":"R. Soc. Open Sci."},{"key":"ref_8","first-page":"741","article-title":"Tumor oxygenation: A matter of supply and demand","volume":"16","author":"Gulledge","year":"1996","journal-title":"Anticancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mrfmmm.2004.06.054","article-title":"Cellular reaction to hypoxia: Sensing and responding to an adverse environment","volume":"569","author":"Papandreou","year":"2005","journal-title":"Mutat. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_11","first-page":"S241","article-title":"Arteriolar oxygenation in tumour and subcutaneous arterioles: Effects of inspired air oxygen content","volume":"27","author":"Dewhirst","year":"1996","journal-title":"Br. J. Cancer Suppl."},{"key":"ref_12","first-page":"S247","article-title":"Microvascular studies on the origins of perfusion-limited hypoxia","volume":"27","author":"Dewhirst","year":"1996","journal-title":"Br. J. Cancer Suppl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/02841869509093981","article-title":"Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors","volume":"34","author":"Secomb","year":"1995","journal-title":"Acta Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.15252\/embj.201695204","article-title":"Hypoxia-Inducible Factors: Coupling Glucose Metabolism and Redox Regulation with Induction of the Breast Cancer Stem Cell Phenotype","volume":"36","author":"Semenza","year":"2017","journal-title":"EMBO J."},{"key":"ref_15","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1042\/BST20160094","article-title":"The Warburg effect: 80 years on","volume":"44","author":"Potter","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","article-title":"Lactate metabolism in human lung tumors","volume":"171","author":"Faubert","year":"2017","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic heterogeneity in human lung tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI72873","article-title":"Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation","volume":"125","author":"Sellers","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kennedy, K.M., Scarbrough, P.M., Ribeiro, A., Richardson, R., Yuan, H., Sonveaux, P., Landon, C.D., Chi, J.T., Pizzo, S., and Schroeder, T. (2013). Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075154"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","article-title":"An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis","volume":"162","author":"Birsoy","year":"2015","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Sriskanthadevan","year":"2015","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/07357907.2014.907419","article-title":"Importance of glutamine metabolism in leukemia cells by energy production through TCA cycle and by redox homeostasis","volume":"32","author":"Goto","year":"2014","journal-title":"Cancer Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-017-0667-y","article-title":"ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells","volume":"16","author":"Cesi","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1158\/0008-5472.CAN-14-1392","article-title":"Inhibition of mTORC1\/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1alpha and oxidative phosphorylation in melanoma","volume":"74","author":"Gopal","year":"2014","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"key":"ref_31","first-page":"106","article-title":"Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside","volume":"46","author":"Piert","year":"2005","journal-title":"J. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.2967\/jnumed.107.045914","article-title":"Molecular imaging of hypoxia","volume":"49","author":"Krohn","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_33","first-page":"1886","article-title":"Kinetics and mechanism of bioreduction of nitroimidazoles as hypoxia probes","volume":"21","author":"Ballesteros","year":"2013","journal-title":"Proc. Intl. Mag. Reson. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.apradiso.2004.12.004","article-title":"Preparation of the hypoxia imaging PET tracer [18F]FAZA: Reaction parameters and automation","volume":"62","author":"Reischl","year":"2005","journal-title":"Appl. Radiat. Isot."},{"key":"ref_35","first-page":"39","article-title":"Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles","volume":"59","author":"Peeters","year":"2015","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/01621459.1961.10482090","article-title":"Multiple comparisons among means","volume":"56","author":"Dunn","year":"1961","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/nchembio.2195","article-title":"SF2312 is a natural phosphonate inhibitor of enolase","volume":"12","author":"Leonard","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature11331","article-title":"Passenger deletions generate therapeutic vulnerabilities in cancer","volume":"488","author":"Muller","year":"2012","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-015-0138-0","article-title":"Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth","volume":"3","author":"Schockel","year":"2015","journal-title":"Cancer Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14766","DOI":"10.1073\/pnas.97.26.14766","article-title":"Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase","volume":"97","author":"Salomon","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Straud, S., Zubovych, I., De Brabander, J.K., and Roth, M.G. (2010). Inhibition of iron uptake is responsible for differential sensitivity to V-ATPase inhibitors in several cancer cell lines. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011629"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine metabolism in cancer: Understanding the heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jlcr.1865","article-title":"Highlighting the versatility of the Tracerlab synthesis modules. Part 1: Fully automated production of [F]labelled radiopharmaceuticals using a Tracerlab FX(FN)","volume":"54","author":"Shao","year":"2011","journal-title":"J. Labelled Comp. Radiopharm."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yanfei, L., Han, Y., Qian, F., and Baofa, Y. (2016). Preclinical pharmacokinetics and toxic kinetics study of 2, 4-dinitrophenol (DNP). Pharm. Pharmacol. Int. J., 4.","DOI":"10.15406\/ppij.2016.04.00096"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Takakusagi, Y., Matsumoto, S., Saito, K., Matsuo, M., Kishimoto, S., Wojtkowiak, J.W., DeGraff, W., Kesarwala, A.H., Choudhuri, R., and Devasahayam, N. (2014). Pyruvate induces transient tumor hypoxia by enhancing mitochondrial oxygen consumption and potentiates the anti-tumor effect of a hypoxia-activated prodrug TH-302. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107995"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(02)52003-6","article-title":"Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5","volume":"352","author":"Koch","year":"2002","journal-title":"Methods Enzymol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001","journal-title":"J. Neurosurg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2967\/jnumed.116.188557","article-title":"In vivo relationship between hypoxia and angiogenesis in human glioblastoma: A multimodal imaging study","volume":"58","author":"Ponte","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00259-011-2037-0","article-title":"18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas","volume":"39","author":"Hirata","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","article-title":"[18F]-FMISO PET study of hypoxia in gliomas before surgery: Correlation with molecular markers of hypoxia and angiogenesis","volume":"44","author":"Bekaert","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_52","first-page":"1","article-title":"Linking metabolic reprogramming to therapy resistance in cancer","volume":"1868","author":"Morandi","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1alpha balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells","volume":"22","author":"Sancho","year":"2015","journal-title":"Cell Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"12647","DOI":"10.1074\/jbc.M109.084194","article-title":"Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization","volume":"285","author":"Hao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_55","first-page":"1","article-title":"The Pasteur effect and the relations between respiration and fermentation","volume":"8","author":"Krebs","year":"1972","journal-title":"Essays Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1042\/bst0311143","article-title":"Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation","volume":"31","author":"Holness","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1095-6433(03)00007-2","article-title":"Glycolysis and pyruvate oxidation in cardiac hypertrophy\u2014Why so unbalanced?","volume":"135","author":"Leong","year":"2003","journal-title":"Comp. Biochem. Physiol. A. Mol. Integr. Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(01)00518-9","article-title":"HIF-1, O(2), and the 3 PHDs: How animal cells signal hypoxia to the nucleus","volume":"107","author":"Semenza","year":"2001","journal-title":"Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2012.04.011","article-title":"Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: A comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry","volume":"105","author":"Tran","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_60","first-page":"203","article-title":"Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA\u2014First small animal PET results","volume":"10","author":"Reischl","year":"2007","journal-title":"J. Pharmacy Pharm. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1074\/jbc.M809101200","article-title":"Complex I is rate-limiting for oxygen consumption in the nerve terminal","volume":"284","author":"Telford","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pnmrs.2011.04.002","article-title":"In vivo oxygen-17 NMR for imaging brain oxygen metabolism at high field","volume":"59","author":"Zhu","year":"2011","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/1078-0432.CCR-14-0217","article-title":"18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243","volume":"21","author":"Chang","year":"2015","journal-title":"Clin. Cancer. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/0284186X.2010.510145","article-title":"Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer","volume":"49","author":"Schuetz","year":"2010","journal-title":"Acta Oncol"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00259-009-1154-5","article-title":"Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA)","volume":"36","author":"Postema","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2967\/jnumed.112.103523","article-title":"Image-guided PO2 probe measurements correlated with parametric images derived from 18F-fluoromisonidazole small-animal PET data in rats","volume":"53","author":"Bartlett","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/micc.12072","article-title":"Quantitative mapping of hemodynamics in the lung, brain, and dorsal window chamber-grown tumors using a novel, automated algorithm","volume":"20","author":"Fontanella","year":"2013","journal-title":"Microcirculation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13550-014-0027-5","article-title":"Detecting functional changes with [18F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy","volume":"4","author":"Chapman","year":"2014","journal-title":"EJNMMI Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1158\/1078-0432.CCR-09-1676","article-title":"Pharmacologically increased tumor hypoxia can be measured by 18F-Fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104","volume":"15","author":"Cairns","year":"2009","journal-title":"Clin. Cancer. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/17520363.1.3.399","article-title":"Use of pharmacokinetic\/pharmacodynamic biomarkers to support rational cancer drug development","volume":"1","author":"Sarker","year":"2007","journal-title":"Biomark Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/S0959-8049(02)00413-6","article-title":"PET for in vivo pharmacokinetic and pharmacodynamic measurements","volume":"38","author":"Gupta","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40262-016-0450-z","article-title":"Genotypes affecting the pharmacokinetics of anticancer drugs","volume":"56","author":"Bertholee","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/labinvest.3700680","article-title":"Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX","volume":"87","author":"Iakovlev","year":"2007","journal-title":"Lab. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/1874471010666171108162319","article-title":"18F-FAZA PET\/CT in the preoperative evaluation of NSCLC: Comparison with 18F-FDG and immunohistochemistry","volume":"11","author":"Mapelli","year":"2018","journal-title":"Curr. Radiopharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2015.07.012","article-title":"Assessment of hypoxic subvolumes in laryngeal cancer with 18F-fluoroazomycinarabinoside (18F-FAZA)-PET\/CT scanning and immunohistochemistry","volume":"117","author":"Bollineni","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1748-717X-6-171","article-title":"Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications","volume":"6","author":"Wenzl","year":"2011","journal-title":"Radiat. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/028418600750013267","article-title":"Development of radiation therapy optimization","volume":"39","author":"Brahme","year":"2000","journal-title":"Acta Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1158\/1078-0432.CCR-14-0858","article-title":"Molecular pathways: A novel approach to targeting hypoxia and improving radiotherapy efficacy via reduction in oxygen demand","volume":"21","author":"Lin","year":"2015","journal-title":"Clin. Cancer. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"24188","DOI":"10.1074\/jbc.M116.749978","article-title":"Identification of small molecule inhibitors of human cytochrome c oxidase that target chemoresistant glioma cells","volume":"291","author":"Oliva","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"37568","DOI":"10.18632\/oncotarget.17247","article-title":"Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit","volume":"8","author":"Oliva","year":"2017","journal-title":"Oncotarget"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2967\/jnumed.115.167650","article-title":"Measurement of tumor hypoxia in patients with advanced pancreatic cancer based on 18F-Fluoroazomyin arabinoside uptake","volume":"57","author":"Yeung","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00259-014-2730-x","article-title":"A prospective clinical study of [18F]-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy","volume":"41","author":"Differding","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/0284186X.2017.1287943","article-title":"Evolution of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside PET uptake distributions in lung tumours during radiation therapy","volume":"56","author":"Lee","year":"2017","journal-title":"Acta Oncol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/12\/1487\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:34Z","timestamp":1760189794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/12\/1487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cells8121487"],"URL":"https:\/\/doi.org\/10.3390\/cells8121487","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}